Angelo Armandi
282 works · 4,011 citations · h-index 31
Top works
- Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis
- Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
- Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
- Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
- Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
- An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
- Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
- Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study
- From “Burnt-Out” to “Burning-Out”: Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction–Associated Steatotic Liver Disease From a Dynamic Perspective
- Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
- Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
- Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
- Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease
- Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD
- Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals
- Association between longitudinal weight change and clinical outcome in individuals with MASLD
- Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
- When to Switch to Subcutaneous Infliximab? The RE-WATCH Multicenter Study
- Epidemiology of Inflammatory Bowel Diseases: A Population Study in a Healthcare District of North-West Italy
- Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease